博彥科技(002649.SZ)2021年度淨利潤預增11.83%-29.97%
格隆匯1月26日丨博彥科技(002649.SZ)公佈,預計2021年度歸屬於上市公司股東的淨利潤3.7億元-4.3億元,同比增長11.83%-29.97%;扣除非經常性損益後的淨利潤3.3億元-3.9億元,同比增長12.29%-32.70%。
2021年度,公司以“優化、增長”作為發展關鍵詞,積極抓住各行業數字化轉型的發展機會,深化與大客户的戰略合作和生態合作,憑藉專業全面的技術積累和服務能力,促進整體業務呈現良性發展態勢。同時,公司不斷優化業務結構,聚焦金融垂直行業領域業務發展,持續拓展金融科技相關業務佈局,推動公司營業收入和淨利潤實現穩健增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.